Back to Search Start Over

Compugen Announces New U.S. Patent for Methods of Screening for Anti-PVRIG Antibodies

Source :
PR Newswire. February 4, 2020
Publication Year :
2020

Abstract

HOLON, Israel, Feb. 4, 2020 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, announced today that the United States Patent and [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
PR Newswire
Publication Type :
News
Accession number :
edsgcl.613132727